Bayer Aktiengesellschaft (WSE:BAY)

Market Cap	189.23B +109.8%
Revenue (ttm)	195.71B -1.9%
Net Income	-844.87M
EPS	-0.86
Shares Out	n/a
PE Ratio	n/a
Forward PE	9.15
Dividend	0.47 (0.25%)
Ex-Dividend Date	Apr 28, 2025

Volume	5
Average Volume	159
Open	198.18
Previous Close	n/a
Day's Range	198.18 - 198.18
52-Week Range	79.48 - 198.18
Beta	n/a
RSI	66.74
Earnings Date	Feb 25, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1863
• Employees: 88,502
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: BAY

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR